New Cancer Drug Fights Tumors in Those With BRCA Mutations
Olaparib prevents malignant cells from repairing themselves, researchers say
More information
For more information on BRCA1 and BRCA2 cancer, visit the U.S. National Cancer Institute.
advertisement








